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he assembly of gap junctions (GJs) is a process coor-
dinated by growth factors, kinases, and other signaling
molecules. GJ assembly can be enhanced via the
elevation of cAMP and subsequent stimulation of connexon
trafﬁcking to the plasma membrane. To study the positive
regulation of GJ assembly, ﬁbroblasts derived from connexin
(Cx)43 knockout (KO) and wild-type (WT) mice were
 
transfected with WT Cx43 (
 
WT
 
Cx43) or mutant Cx43. GJ
assembly between untransfected WT ﬁbroblasts or stably
transfected 
 
WT
 
Cx43/KO ﬁbroblasts was increased two- to
ﬁvefold by 8Br-cAMP, and this increase could be blocked
by inhibition of cAMP-dependent protein kinase (PKA) or
truncation of the Cx43 COOH terminus (CT). Although
T
 
serine 364 (S364) of the Cx43 CT was determined to be a
major site of phosphorylation, the molar ratio of Cx43
phosphorylation was not increased by 8Br-cAMP. Importantly,
GJ assembly between either 
 
S364E
 
Cx43/KO or
 
 S364E
 
Cx43/WT
ﬁbroblasts was stimulated by 8Br-cAMP, but that between
 
S364A
 
Cx43/KO or 
 
S364P
 
Cx43/KO ﬁbroblasts was not stimulated,
indicating that phosphorylation or a negative charge at
S364 is required for enhancement of GJ assembly by
 
cAMP. Furthermore, GJ assembly between 
 
S364A
 
Cx43/WT
ﬁbroblasts could be stimulated by 8Br-cAMP, but could
not be between 
 
S364P
 
Cx43/WT ﬁbroblasts. Thus, 
 
S364P
 
Cx43
interferes with enhanced GJ assembly when coexpressed
with 
 
WT
 
Cx43.
 
Introduction
 
Gap junction (GJ)* proteins (termed connexins [Cxs]),
comprise a family of vertebrate transmembrane proteins that
assemble intracellularly to form oligomeric channels (Musil
and Goodenough, 1993). The GJ hemichannels, or connexons,
are transported to the plasma membrane where they dock
with connexons in the membranes of adjacent cells and
aggregate to mediate intercellular transfer of various ions,
signaling molecules, and metabolites (Simon and Good-
enough, 1998). The essential role of GJ communication in
the coordination of physiological processes within various tis-
sues has become increasingly apparent, with defects in the
different Cx proteins now linked to a wide variety of patho-
logical conditions (Krutovskikh and Yamasaki, 2000).
The GJ protein Cx43 is one of the more ubiquitous of the
GJ proteins. Its importance is underscored by the abnormal
heart development, perinatal mortality, female sterility,
altered bone development, and cataracts observed in Cx43
knockout (KO) mice (Lo, 1999). Its unique characteristics
are further emphasized by studies of “knock-in” mice, in
which replacement of Cx43 with Cx32 or Cx40 results in
mice with germ-cell deficiencies and mild cardiac defects
(Plum et al., 2000). Considerable research has focused on
the gating or regulation of Cx43 in established GJs; much
less attention has focused on the regulation of the assembly
of Cx43-containing GJs. Yet, the relatively short half-life of
Cx43, measuring only 2–3 h (Laird et al., 1991; Musil and
Goodenough, 1991; Lampe, 1994), implies that assembly of
Cx43-containing GJs must be a continual process in even
fully differentiated tissues (Beardslee et al., 1998). The
formation of new GJs likely plays an important role during
development and differentiation (De Sousa et al., 1993;
Zhang and Thorgeirsson, 1994), cell division (Lampe et al.,
1998), wound repair (Larson et al., 1997), glandular secre-
tion (Charollais et al., 2000), and parturition (Hendrix et al.,
1995). The transient formation of GJs between blood cells
and other cell types is also recognized, although the reasons
for such formation remain speculative (Saez et al., 2000).
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Cx43-mediated communication (Darrow et al., 1995),
the size and number of GJs (Atkinson et al., 1995), and the
assembly of new GJs (Paulson et al., 2000) can all be en-
hanced by agents that elevate intracellular cAMP. Such en-
hancement has been shown to result from increased synthe-
sis (Mehta et al., 1992) and/or the increased trafficking of
connexons to the plasma membrane (Burghardt et al., 1995;
Holm et al., 1999; Paulson et al., 2000). We have previously
shown that cAMP-enhanced GJ assembly is mediated by
cAMP-dependent protein kinase (PKA), and that the activa-
tion of PKA is required prior to or during GJ assembly
(Paulson et al., 2000). There are reports that microinjected
PKA catalytic subunit affects GJ communication within
minutes (Godwin et al., 1993; Britz-Cunningham et al.,
1995), consistent with an effect on channel gating or open
time. However, as we show here, the assembly of new GJs
can also take place within minutes. Moreover, direct phos-
phorylation of Cx43 by PKA has not been documented, and
activation of PKA does not result in a change in single chan-
nel conductance of Cx43 expressed in SKHep cells (Kwak et
al., 1995).
A large number of known and potential phosphorylation
sites, protein kinase binding sites, and a ZO-1 binding site
all reside on the COOH-terminal domain of Cx43 (Giep-
mans et al., 2000; Lampe and Lau, 2000; Toyofuku et al.,
2000). A variety of COOH terminus (CT) sites and do-
mains have also been identified that play a role in Cx43
channel gating, e.g., in a reduced pH environment (Ek-
Vitorin et al., 1996). Importantly, when truncated Cx43 is
expressed in mammalian cells, growth control and the re-
sponse to PDGF are defective (Moorby and Gherardi,
1999). Therefore, it appears that although the Cx43 CT is
not required for formation of functional GJs, the CT is crit-
ical for GJ regulation.
Several studies have indicated that serine 364 (S364) is an
important site on the COOH-terminal domain of Cx43.
S364 resides in a tandem RXSSR protein kinase C (PKC)-
specific repeat found from R362–R374. An S-to-proline
conversion at 364 (S364P) was first identified in vivo as a
mutation in a subset of patients with visceral atrial hetero-
taxia, and GJs formed from 
 
S364P
 
Cx43 in vitro displayed an
altered response to PKC- or PKA-related signaling cascades
(Britz-Cunningham et al., 1995). In spite of the fact that
Cx43 mutations have not been identified in other popula-
tions of visceral atrial heterotaxia patients (Debrus et al.,
1997), 
 
S364P
 
Cx43 affects left-right patterning in the early 
 
Xe-
nopus
 
 embryo when misexpressed dorsally, resulting in a sig-
nificant increase in heterotaxia (Levin and Mercola, 1998).
The S364P mutation also significantly alters the pH sensi-
tivity of Cx43 gating in the 
 
Xenopus
 
 oocyte expression sys-
tem (Ek-Vitorin et al., 1996). As a result of these findings,
we investigate here whether mutation of this site also affects
the regulation of GJ assembly.
Although PKA plays an important role in the regulation
of Cx43 GJ assembly in cAMP-treated cells in vitro, it is yet
unclear how such regulation is effected. To better under-
stand this relationship, we have examined GJ assembly in
several cell types transfected with COOH-terminal mutants
of Cx43. These studies show that the upregulation of GJ as-
sembly requires an intact COOH-terminal domain, and
suggest a need for an appropriate conformation around posi-
tion 364, potentially to facilitate Cx43CT interactions with
other proteins that regulate GJ assembly. Furthermore, a
negative charge at this site, such as would occur upon phos-
phorylation, appears to be a prerequisite for cAMP stimula-
tion of GJ assembly.
 
Results
 
Enhancement of GJ assembly between mouse 
fibroblasts by activation of PKA
 
Established WT fibroblasts expressing endogenous 
 
WT
 
Cx43
typically display a two- to fourfold enhancement of GJ com-
munication after exposure to cell permeant 8Br-cAMP for
3–4 h (e.g., clone 10-8 average recipient cells for control:
18.5 
 
 
 
 0.31, 
 
n 
 
  
 
10; 8Br-cAMP: 37.0 
 
 
 
 2.69, 
 
n 
 
  
 
10). A
complement to the WT fibroblast, the KO fibroblast, was
used for the majority of these studies, as it likely provides a
similar physiological milieu suitable for the reintroduction
and study of Cx43 (Fig. 1). Lucifer yellow dye transfer is ab-
sent between untransfected KO fibroblasts, and whole-cell
conductance values are as low, if not lower, than those of
other null cells (Kwak et al., 1995; Martyn et al., 1997).
To evaluate the cAMP responsiveness of GJ assembly,
cells were treated with the cell-permeant cAMP analogue,
8Br-cAMP, and an inhibitor of PKA, 
 
N
 
-(2-[{p-bromocin-
namyl} amino]ethyl)-5-isoquinolinesulfonamide dihydro-
chloride (H89), was used to establish whether cAMP-
enhanced assembly was dependent on PKA (Paulson et al.,
2000). To induce the assembly of new GJs, cells were
trypsin dissociated, recovered for a period of time sufficient
Figure 1.  Stimulation of GJ assembly after the elevation of cAMP. 
Two separate, representative experiments (dark vs. light bars) com-
paring GJ assembly between untreated WTCx43/KO fibroblasts 
(clone 22C-3) and cells treated with 8Br-cAMP, with both 8Br-cAMP 
and H89, or with H89 alone. (Dark bars) When present, H89 was 
added at recovery. (Light bars) When present, H89 was added 15 
min before reaggregation. 
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to ensure removal of GJ remnants from the cell surface, and
finally reaggregated as a confluent monolayer for 7–60 min
depending on the experiment (Materials and methods). A
two- to threefold increase in GJ assembly, as measured by
transfer of microinjected dye, was seen following treatment
of 
 
WT
 
Cx43/KO fibroblasts with 8Br-cAMP (350 
 
 
 
M) for
both recovery and reaggregation (assembly) (Fig.1). This in-
crease was blocked when H89 (30 
 
 
 
M) was added either at
the beginning of recovery or 15 min before reaggregation.
Nearly identical results were achieved using WT fibroblasts
(e.g., 30 min assembly, clone 10-7 control: 13.0 
 
 
 
 1.5, 
 
n
 
 
 
 
 
10; 8Br-cAMP [4.5 h]: 24.8 
 
 
 
 1.8, 
 
n
 
 
 
  
 
10; 8Br-cAMP 
 
 
 
H89 [4.5 h]: 13.8 
 
 
 
 2.2, 
 
n 
 
  
 
10; H89 alone [4.5 h]: 10.8 
 
 
 
1.4, 
 
n 
 
  
 
10).
 
Synthesis of Cx43 is not required for enhanced 
GJ assembly
 
To determine whether elevated cAMP stimulated the syn-
thesis of Cx43, Western immunoblotting and densitometry
were used to monitor Cx43 levels in cell homogenates from
assembly experiments. 8Br-cAMP treatment during the as-
sembly assay elevated total Cx43 in WT fibroblasts by 26%
Figure 2.  The effects of cycloheximide 
on GJ assembly. Representative experi-
ments comparing GJ assembly between 
WT fibroblasts (A) (clone 10-3) untreated 
(1) or treated with 8Br-cAMP (2), cyclo-
heximide (3), or both cycloheximide and 
8Br-cAMP (4). Cells were recovered for 
4 h 23 min in suspension and reaggre-
gated for 7 min (light bars) or recovered 
for 3.5 h in suspension and reaggregated 
for 1 h (dark bars). (Inset) Western 
immunoblot of WT fibroblasts after 1-h 
assembly (dark bars). (B) Immunolocal-
ization of Cx43 using Cx43IF1 mouse 
monoclonal antibody (1:10), detected by 
goat anti–mouse Alexafluor 568 (1:500). 
WT fibroblasts were recovered for 3.5 h 
in suspension and reaggregated for 1 h 
before fixation. When present, 8Br-cAMP 
and/or cycloheximide were added at the 
beginning of recovery. (A) control; (B) 
8Br-cAMP; (C) cycloheximide; (D) 
cycloheximide   8Br-cAMP. 
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on average (
 
n 
 
  
 
6; 4.5-h treatment time) (Fig. 2 A, inset). In
contrast, expression levels were not significantly elevated by
8Br-cAMP in 
 
WT
 
Cx43- or mutant Cx43-transfected KO fi-
broblasts after correcting for loading differences (unpub-
lished data; see Fig. 5 B).
To further test whether increased synthesis of Cx43 was
required for cAMP-enhanced assembly, the protein synthesis
inhibitor, cycloheximide, was added either at the beginning
of recovery or just prior to reaggregation (assembly) of the
WT or 
 
WT
 
Cx43/KO fibroblasts. GJ assembly was measured
by the degree of dye coupling, and the amount of Cx43 pro-
tein was evaluated by Western immunoblotting. When cy-
cloheximide was added to 
 
WT
 
Cx43/KO at the beginning of a
30-min reaggregation, GJ assembly was inhibited by 50%.
These lower levels of assembly were still doubled by 8Br-
cAMP and Cx43 levels remained unchanged (clone 22C-3,
control: 6.5 
 
 
 
 0.8, 
 
n 
 
  
 
17; 8Br-cAMP: 14.1 
 
 
 
 1.3, 
 
n 
 
 
 
15; cycloheximide: 3 
 
 
 
 0.4, 
 
n 
 
  
 
16; 8Br-cAMP 
 
 
 
 cyclo-
heximide 6.5 
 
 
 
 0.5, 
 
n 
 
  
 
17). However, when cyclohexim-
ide was introduced at the beginning of recovery with either
the WT
 
 
 
or 
 
WT
 
Cx43/KO fibroblasts, the inhibition of control
and enhanced levels of GJ assembly was nearly complete in
spite of the detection of significant levels of Cx43 (Fig. 2 A,
inset; unpublished data). Although significant levels of cou-
pling developed by 7–15 min of assembly, immunolabeling
failed to show discernible GJ punctae at interfaces in either
controls or 8Br-cAMP–treated samples (unpublished data).
Interestingly, when reaggregation was extended, to allow for
a greater degree of GJ assembly, samples treated with cyclo-
heximide for the entire assay developed detectable punctae
at interfaces and relatively high levels of coupling (Fig. 2, A
and B), indicating that GJ assembly was slowed but not
blocked by cycloheximide. In spite of this, 8Br-cAMP stim-
ulation of GJ assembly detected by either dye transfer or im-
munolabel was completely blocked by a 4.5-h treatment of
cycloheximide with the longer assembly (Fig. 2, A and B).
Thus, the enhancement of GJ assembly by cAMP is not de-
pendent on new synthesis of Cx43, but may be dependent
on the synthesis of another protein, possibly one that pos-
sesses a relatively short half-life. In addition, the level of un-
stimulated GJ assembly appears also to be affected by a cy-
cloheximide-sensitive protein.
 
Gap junction assembly between 
 
M257
 
Cx43 transfectants
 
A primary objective of this study was to determine whether
specific domains of the Cx43 CT are required for the posi-
tive regulation of GJ assembly by intracellular cAMP. As a
first step in addressing this objective, 
 
M257
 
Cx43 cDNA was
transfected into the KO fibroblasts to determine whether re-
moval of most of the predicted Cx43 phosphorylation and
regulatory sites would interfere with either control or en-
hanced levels of GJ assembly. Of two transfections, only
31% (29/93) of the stably transfected
 
 M257
 
Cx43/KO fibro-
blast clones were found to minimally transfer Lucifer yellow
dye, compared with 72% (36/50) of the 
 
WT 
 
Cx43/KO fibro-
blast clones. Importantly, and in contrast to the 
 
WT
 
Cx43/
KO fibroblasts, treatment of weakly coupled 
 
M257
 
Cx43/KO
fibroblasts with 8Br-cAMP, as either assembling or estab-
lished monolayers, had no effect on dye transfer (e.g., clone
TR22B, control: 1.82 
 
 
 
 0.87, 
 
n 
 
  
 
11; 8Br-cAMP: 1.55 
 
 
 
0.62, 
 
n 
 
  
 
11). Dye transfer disappeared between the
 
M257
 
Cx43/KO fibroblast subclones with increased passage in
spite of continued expression of significant levels of protein.
Immunolabel of 
 
M257
 
Cx43/KO fibroblasts confirmed that
significant levels of truncated Cx43 resided within the cell
cytoplasm, with very little localizing to interfaces (unpub-
lished data).
Because 
 
M257
 
Cx43 did not form significant GJs in the fi-
broblast, N2A cells that had been previously transfected
with 
 
WT
 
Cx43 or 
 
M257
 
Cx43 were also examined. Prior to
transfection, N2A cells have a very low level of electrical
coupling measured by double whole-cell patch clamp that is
reportedly the result of Cx45 expression (Veenstra et al.,
1992). We detected no Lucifer yellow dye coupling between
parental N2A cells (0.18 
 
  
 
0.4; 
 
n 
 
  
 
10), and 8Br-cAMP
treatment (4.5 h) failed to stimulate coupling (0 
 
  
 
0; 
 
n 
 
 
 
10). Confluent monolayers of 
 
WT
 
Cx43/N2A and 
 
M257
 
Cx43/
Figure 3.  Comparison of cells expressing WTCx43 or M257Cx43. 
(A) A representative experiment in which established monolayers of 
WTCx43/N2A and 
M257Cx43/N2A cells were treated with or without 
8Br-cAMP for 4.5 h and coupling measured by microinjection of 
Lucifer yellow dye. (B) A representative experiment comparing de 
novo GJ assembly between 
WTCx43/N2A and 
M257Cx43/N2A cells 
treated for the entire experiment with or without 8Br-cAMP.
*0.001   P   0.01 
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N2A, cells were found to be equally well dye coupled, and
treatment of established 
 
WT
 
Cx43/N2A monolayers with
8Br-cAMP for 4.5 h increased coupling three- to fourfold,
whereas coupling between the 
 
M257
 
Cx43/N2As remained at
control levels (Fig. 3 A). When the same cells were dissoci-
ated, recovered, and reaggregated in the presence or absence
of 8Br-cAMP, GJ assembly between the 
 
WT
 
Cx43/N2As was
significantly increased, but that between the 
 
M257
 
Cx43/N2As
remained unchanged (Fig. 3 B). The 
 
M257
 
Cx43/N2A cells
also assembled GJs more slowly than the 
 
WT
 
Cx43/N2A cells
did, in spite of communicating equally well in established
monolayers (Fig. 3, compare A and B). Thus, as was found
using the less well-coupled 
 
M257
 
Cx43/KO fibroblasts, these
data show that the Cx43 CT affects the kinetics of basal GJ
assembly and that the CT is required for enhanced GJ as-
sembly.
 
Cx43 is phosphorylated at S364 in unstimulated cells
 
PKA regulation of GJ communication is reportedly altered
when S364 of Cx43 is mutated to a proline (Britz-Cunning-
ham et al., 1995). This information, in addition to a need
for the CT of Cx43 in basal and enhanced assembly, and the
indication that PKA is required for enhanced and possibly
basal GJ assembly, led us to question whether specific sites
on the CT were phosphorylated during GJ assembly. As pre-
vious studies have suggested that Cx43 is phosphorylated
during GJ assembly to a P2 phospho-form (Musil and
Goodenough, 1991), we first purified P2 from Cx43 in un-
treated confluent T51B cells for analysis. T51B cells were
used because they express abundant Cx43 with a phosphory-
lation pattern resembling that of Cx43 in WT fibroblasts.
After trypsin digestion and separation of phosphorylated
from nonphosphorylated peptides, matrix-assisted laser de-
sorption ionization–time of flight (MALDI-TOF) mass spec-
tometry (MS) indicated that one of the major fragments had
a mass of 2,224. This matches the calculated mass of tryptic
peptide V347-R366 plus 80 (the mass of a single phos-
phate). Consistent with this tentative identification, the
nonphosphorylated fraction contained a fragment of 2,144,
the predicted mass of unphosphorylated V347-R366. The
nonphosphorylated fraction also contained several other
fragments with masses consistent with Cx43 (e.g., Y265-
K287). Finally, tandem MS analysis yielded secondary frag-
ments that had masses consistent with those expected
from phosphorylated and nonphosphorylated peptide V347-
R366. V347-R366 contains no threonine or tyrosine resi-
dues and only two serine residues, S364 and S365, near the
COOH-terminal end of the peptide. Their adjacency and
position near the CT make positive identification of the spe-
cific phosphorylated residue(s) impractical using these tech-
niques. We know from previous research that the P2 form of
Cx43 is phosphorylated at multiple serine residues found on
several different peptides after trypsin digestion (Berthoud et
al., 1993; Saez et al., 1997; Lampe and Lau, 2000). As the
Figure 4.  S364 of Cx43 is phosphorylated in unstimulated 
WTCx43/KO fibroblasts. (A) HPLC elution profile for 
32P-labeled Cx43 peptides 
isolated from cells expressing 
WTCx43 ( ) or 
S364PCx43 ( ). The elution position of certain peptides is indicated. Amino acids 346–382 of 
Cx43 and tryptic cleavage sites are depicted above the profile (arrows). Asterisks denote sites that may only be partially cleaved by trypsin. (B) 
Autoradiogram depicting in vitro phosphorylation of Cx GST fusion proteins. (Lane 1) Purified GST CTCx56 phosphorylated by PKA. (Lane 2) 
Purified GST CTCx43 phosphorylated by of PKA. (Lane 3) Purified GST CTCx43 phosphorylated by PKC. (C) Phosphorylation of Cx43 after 
treatment with 8Br-cAMP. Autoradiogram showing results of two separate experiments in which confluent monolayers of WT fibroblasts 
(10-3) were loaded with radiolabeled [
32P]i in the presence or absence of 8Br-cAMP (Materials and methods). (1 and 3) Untreated. (2 and 4) 
Treated with 8Br-cAMP.1312 The Journal of Cell Biology | Volume 155, Number 7, 2001
peptide containing S364 and S365 isolated from T51B cells
was prominent, it is likely that phosphorylation of this pep-
tide is a major phosphorylation in P2. Data from many of
the other peptides detected by MS will need to be verified in
other studies.
In an attempt to ascertain which residue(s) of the S364–
S365-containing peptide was phosphorylated, 
WTCx43/ or
S364PCx43/KO fibroblasts were metabolically labeled with
[
32P]i, Cx43 was immunoprecipitated, and tryptic peptides
were analyzed by HPLC. The 
WTCx43-expressing cells in-
corporated 3,400 cpm, and the 
S364PCx43 cells incorporated
1,200 cpm that could be recovered in tryptic fragments.
HPLC separation of labeled Cx43 from 
WTCx43 cells re-
vealed peaks of radioactivity eluting at 8, 21–22, and 24
min, whereas separation of labeled 
S364PCx43 revealed peaks
at 8 and 20–21 min, consistent with 
WTCx43 cells, and sev-
eral other smaller peaks (Fig. 4 A). Comparison of common
peaks showed a 29-fold greater incorporation of 
32P in the
8-min fraction from 
WTCx43 as related to the same fraction
from 
S364PCx43, whereas the 20–21-min fractions contained
much closer to equal levels of radioactivity. We have previ-
ously shown that when the sequence A367-R370 was phos-
phorylated at S368, it eluted at 8 min using this HPLC sys-
tem (Lampe et al., 2000). We expect P363S(
32P)SR to also
elute in the 8-min fraction, as its charge is nearly identical
and its mass only differs from phosphorylated A367-R370
by 26 Da.
MALDI-TOF MS indicated that the radiolabeled frac-
tions that eluted at 20–21 min (Fig. 4 A) contained peptides
(derived from GST–Cx43CT) with masses of 1355 and
Figure 5.  GJ assembly between 
S364PCx43, 
S364ECx43 and 
S364ACx43/KO 
fibroblasts. (A) Example of Lucifer 
yellow dye transfer between 
S364PCx43 
and 
S364ECx43/KO fibroblasts assembled 
overnight into confluent monolayers 
(*, injected cell). (B) Representative 
immunoblot of 
S364PCx43, 
S364ECx43, or 
S364ACx43/KO homogenates after GJ 
assembly and treatment without (1, 3, 5) 
or with (2, 4, 6) 8Br-cAMP for the entire 
assay. To detect 
S364PCx43 and 
S364ECx43 
(arrowhead), membranes were labeled 
with a Cx43 antibody (1:8,000; Sigma-
Aldrich) and detected with peroxi-
dase-conjugated secondary antibody
(1:10,000). A cross-reactive product, 
which was not consistently detected, 
is indicated below NP 
S364ECx43 (small 
arrowhead). (C) Compilation of representative GJ assembly experiments from 
S364PCx43, 
S364ECx43, and 
S364ACx43/KO fibroblasts. Cells were 
recovered for 4 h, reaggregated for 30 min, and, where indicated, treated with 8Br-cAMP for the entire 4.5 h of the assembly experiment. N 
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2778, consistent with the mass expected for A371-I382 and
M320-K345 (see Materials and methods). Because the 20–
21-min fractions from either 
WTCx43 or 
S364PCx43 cells held
significant radioactivity, the S364P mutation did not appear
to affect phosphorylation in these two peptides. However,
WTCx43-expressing cells showed a third peak eluting at 24
min that was not found with 
S364PCx43 cells (Fig. 4 A).
MALDI-TOF MS showed that the radiolabeled
 WTCx43
peak fraction at 24 min contained tryptic fragments with
masses of 2,144 and 1,717, consistent with V347-R366 and
V347-R362, which are distinguished by reduced cleavage of
the R-P bond. V347-R366 contains phosphorylatable serine
residues at 364 and 365. Only limited radioactivity was re-
covered in this same fraction from the 
S364PCx43 cells, indi-
cating that the same peptide was not phosphorylated when
S364 was mutated. Likewise, in a different set of experi-
ments, phosphorylation and processing of S364A- and
S364E-expressing cells resulted in only background levels of
Figure 6.  GJ assembly following the expression of vector, 
S364PCx43, 
S364ECx43, 
S364ACx43, or 
WTCx43 in WT fibroblasts. (A) Comparison of 
GJ assembly between WT fibroblasts (10-3) transfected with either 
S364PCx43 or 
S364ECx43 and treated with or without 8Br-cAMP for the entire 
experiment (*, injected cell). (B) Example of immunoblots of cell homogenates following two different assembly experiments using either WT 
fibroblasts transiently transfected with 
M257Cx43 or 
S364PCx43. Cells were transfected 48 h prior to experimentation with either vector alone 
(pIRES; 1, 2, 5, and 6) or mutant construct (3, 4, 7, and 8). Cells were dissociated and recovered for 4 h 15 or 23 min, reaggregated for 15 
(
M257Cx43) or 7 (
S364PCx43) min, and treated either without (1 and 3) or with (2 and 4) 8Br-cAMP for the entire GJ assembly experiment. To 
detect endogenous 
WTCx43 and transfected 
M257Cx43 (arrowhead, first panel) membranes were labeled with NH2-terminal Cx43 antibody 
(1:8,000) detected with goat anti–rabbit peroxidase antibody (1:10,000). To detect mutant and 
WTCx43 expression (second panel), mem-
branes were labeled with Cx43 CT antibody (1:8,000; Sigma-Aldrich) detected with goat anti–rabbit peroxidase antibody (1:10,000). (C) 
Compilation of trials in which WT fibroblasts were transfected with either vector alone, mutant, or WT Cx43 and GJ assembly monitored 
without (A) or with (B) 8Br-cAMP.1314 The Journal of Cell Biology | Volume 155, Number 7, 2001
radioactivity in the HPLC fractions associated with V347-
R366, whereas 
WTCx43-expressing cells showed 98 cpm
(unpublished data). These data support the conclusion that
the presence of S364 is necessary for phosphorylation to oc-
cur on this fragment, and that S365 is not a viable alterna-
tive phosphorylation site in cells when S364 is mutated.
However, these results do not explain why 
S364PCx43 yet dis-
plays a shift in migration of Cx43 in SDS-PAGE in un-
treated cells (Fig 5 B). The most likely explanation is that
phosphorylation within the A371-I382 or M320-K345 frag-
ment, or compensatory phosphorylation represented by the
radioactivity eluting at 11, 14, and 17 min in the 
S364PCx43
run, is sufficient to shift Cx43 to a slower migrating form.
Treatment with 8Br-cAMP does not increase the 
phosphorylation of Cx43
MS is an excellent method for detecting phosphorylation,
but it is not a good method for quantifying such phosphory-
lation, and therefore could not be used to study relative
changes in phosphorylation during enhanced assembly or
the kinases involved. Thus, a Cx43 glutathione sulphotrans-
ferase (GST)–CT fusion protein was used to first test for
phosphorylation by PKA in vitro. As can be seen in Fig. 4 B,
the Cx43 fusion protein was efficiently phosphorylated by
purified PKC, but not by PKA. In contrast, the CT of Cx56
was highly phosphorylated by PKA, indicating that the
preparation was active.
Next, to test whether PKA might act indirectly to increase
the phosphorylation of Cx43 (e.g., at S364), monolayers of
WT fibroblasts were radiolabeled with [
32P]i (1 mCi/ml),
treated with 8Br-cAMP, and Cx43 was immunoprecipi-
tated. A 24% average increase in radiolabeled Cx43 was de-
tected in both trials after a 4-h treatment with 8Br-cAMP
(300  M) (Fig. 4 C). Treatment of parallel cultures with
8Br-cAMP resulted in a significant elevation of dye coupling
(unpublished data). Because Cx43 levels in the same clone
were similarly found to increase by an average of 26% after
8Br-cAMP treatment (as described above; Fig. 2 A, inset),
the small increase in radiolabeled Cx43 detected in these two
experiments is almost certainly due to an increase in immu-
noprecipitated Cx43 (phosphorylated and nonphosphory-
lated) rather than an increase in the molar ratio of phosphor-
ylation. Furthermore, the proportion of P forms remained
constant. Thus, an overall increase in phosphorylation of
Cx43 during enhanced assembly is not likely.
Conversion of S364 to alanine or proline, but not to 
glutamic acid, inhibits enhanced assembly
Because S364 of Cx43 was significantly phosphorylated in
resting cells, we next asked whether phosphorylation at S364
was a prerequisite for basal and/or enhanced levels of GJ as-
sembly. To address this question, 
S364PCx43, 
S364ECx43, and
S364ACx43 mutants were stably expressed in KO fibroblasts,
and GJ assembly was examined between several subclones of
each transfectant. All S364 mutant/KO transfectants com-
municated and expressed high levels of Cx protein (Fig. 5, A
and B; unpublished data). Interestingly, GJ assembly was
only enhanced between the
 S364ECx43/KO fibroblasts in re-
sponse to 8Br-cAMP, and not between the 
S364PCx43 or the
S364ACx43/KO fibroblasts (Fig. 5 C). Because the negative
charge of the acidic glutamic acid (E) may mimic a phos-
phate group, these results suggest that phosphorylation of
S364 is a prerequisite for enhanced but not basal levels of GJ
assembly.
Coexpression of 
S364PCx43 with native Cx43 in WT 
fibroblasts inhibits enhanced GJ assembly
Because homomeric 
S364PCx43 and 
S364ACx43 GJs in KO fi-
broblasts were not positively regulated by 8Br-cAMP, we
questioned whether these mutants, coexpressed with
WTCx43, would affect the regulation of GJ assembly. Thus,
WT fibroblasts were transiently transfected with 
S364PCx43,
S364ECx43, 
S364ACx43, or pIRES vector alone, and assembly
was studied. Transfection with each of these mutants in-
creased both GJ communication after assembly (Fig. 6 A)
and Cx43 levels on westerns (Fig. 6 B) by at least twofold,
indicating that the mutants were strongly expressed and
were forming functional GJs. In keeping with the experi-
ments utilizing stably transfected KO fibroblasts, the
S364PCx43-transfected WT fibroblasts did not display en-
hanced assembly, whereas control pIRES-transfected and
S364ECx43-transfected WT fibroblasts did (Fig. 6, A and
C). In contrast to the results with 
S364ACx43/KO fibro-
blasts, enhanced assembly was observed between the
S364ACx43/WT fibroblasts (Fig. 6 C). However, levels of as-
sembly due to endogenous Cx43 in 
S364ACx43/WT fibro-
blasts were not as significantly augmented by 
S364ACx43 as
they were by the other two mutants (Fig. 6 C), in spite of
similar levels of expression by Western immunoblotting
(unpublished data). Note that transfection of 
WTCx43 into
the WT fibroblasts doubled both basal and enhanced GJ
assembly (Fig 6 C).
As enhancement of GJ assembly by 8Br-cAMP did not oc-
cur in null cells expressing
 M257Cx43, we also questioned
whether coexpression of truncated Cx43 with native 
WTCx43
would allow for enhanced assembly. Because 
M257Cx43
formed minimal GJs in stably transfected KO fibroblasts of
low passage number, it was expected that transient expression
of 
M257Cx43 in WT fibroblasts might also allow for the forma-
tion of homomeric and/or heteromeric GJs. However, al-
though high levels of 
M257Cx43 expression were achieved
within 48 h of transfection (Fig. 6 B, arrowhead), communi-
cation between 
M257Cx43/WT fibroblasts in assembly assays
was either decreased below control levels (two out of four ex-
periments) or unaffected (two out of four experiments). Be-
cause of the mixed results, and because a longer assembly time
of 15 min was utilized, these data are not included in Fig 6 C.
Assuming that both homomeric (
M257Cx43/
M257Cx43) and
heteromeric (
M257Cx43/
WTCx43) connexons were formed and
functional in the 
M257Cx43 transfectants, an increase in con-
trol levels of GJ communication should have occurred. This
was not the case, and a decrease was observed in two instances,
so it is likely that the truncation mutant does not traffic nor-
mally in the fibroblast background and may even inhibit traf-
ficking of endogenous Cx43. GJ assembly was still enhanced
by 8Br-cAMP in the presence of 
M257Cx43 expression, and to
the same extent as cells transfected with vector alone (approxi-
mately twofold), suggesting that primarily homomeric con-
nexons of native 
WTCx43 were responding to cAMP.Role of S364 of Cx43CT in enhanced gap junction assembly | TenBroek et al. 1315
Discussion
The COOH-terminal domain of Cx43 is required for 
efficient GJ assembly
A need for Cx43 to regulate function in the diverse environ-
ments of the different tissues in which it is expressed may ex-
plain the multiple regulatory sites and domains on its rela-
tively long CT. Thus, it is not surprising that the regulation
of GJs formed by truncated 
M257Cx43 is defective in certain
cell types. GJs formed by the 
M257Cx43 in the Xenopus oo-
cyte system are not sensitive to pH, whereas those formed by
WTCx43 are quite sensitive (Ek-Vitorin et al., 1996), and the
expression of 
M257Cx43 in 3T3 A31 fibroblasts prevents
PDGF-induced inhibition of intercellular communication
and appears to alter growth (Moorby and Gherardi, 1999).
Our findings depicting a lack of enhanced assembly between
cells expressing 
M257Cx43 further demonstrate that the CT is
critical for Cx43 GJ regulation by cAMP.
Most of the regulatory domains within the CT must not be
required for trafficking to the cell interface or for successful
docking of channels in adjacent cells, as 
M257Cx43 can assem-
ble into functional GJs in at least some cell types. One would
expect this to be the case, considering that Cx26, the smallest
Cx identified to date, has a cytoplasmic tail of only 15–18
amino acids in length. Further truncation of the Cx43 tail
from amino acids 257 to 245 also does not appear to prevent
the protein from reaching cell membranes and forming chan-
nels with single channel conductances not unlike Cx43
(Dunham et al., 1992; Fishman et al., 1991). Truncation of
Cx43 has been utilized in vitro to obtain a more ordered ar-
ray of assembled hexamers for electron cryocrystallography
studies (Unger et al., 1999), showing that the tail is not
needed for the aggregation of Cx43 hemichannels.
Using freeze fracture microscopy, we have found that
M257Cx43 GJ assembly proceeds more slowly than 
WTCx43 GJ
assembly, with fewer unaggregated particles detected in GJ
formation plaques in spite of similar levels of protein expres-
sion (unpublished data). Although trafficking and assembly of
M257Cx43 occurs, these processes appear to be less effective
upon loss of the CT. There are reports that COOH-terminal
domains of certain other proteins are also required for regu-
lated intracellular trafficking. For example, the endosomal re-
cycling of endothelial-derived G protein–coupled receptor or
the subendosomal trafficking of Glut4 are inhibited by trun-
cation of the CT or removal of certain CT residues (Liu et al.,
1999; Cope et al., 2000). Indeed, a recent report shows that
the CT of Cx43 interacts with microtubules in Rat-1 cells
(Giepmans et al., 2001). As nocodazole treatment inhibits de
novo GJ assembly in the 
WTCx43/KO fibroblast by 60% (un-
published data), it is likely that microtubules are also involved
with assembly in the fibroblast system. The CT may be re-
quired for interaction with the microtubule and efficient tar-
geting of Cx43 to the GJ.
S364 resides in a domain of the Cx43 CT that is critical 
to enhanced assembly
Although S364 is phosphorylated in “resting” cells, its phos-
phorylation is not necessary for GJ communication, as GJ
assembly still occurs between both the 
S364ACx43 and
S364PCx43/ KO fibroblasts, and with a time course like that
seen between 
WTCx43/KO transfectants. However, phos-
phorylation of this site does appear to be necessary for
cAMP stimulation of GJ assembly, as 
S364ACx43 and
S364PCx43/KO fibroblasts do not display enhanced assembly
in response to 8Br-cAMP. That the 
S364ECx43/KO fibro-
blasts do display enhanced assembly in response to cAMP is
consistent with glutamic acid resembling a phosphate in
charge.
Replacement of S364 with P not only blocks phosphoryla-
tion of the mutated site, but also likely alters the native con-
formation of the Cx43 by inducing an obligate bend at the
proline ring (Eyles and Gierasch, 2000). This alteration in
conformation could interfere with the function of other re-
gions on the molecule, such as phosphorylation sites or pro-
tein-binding domains, that are critical for enhanced assem-
bly. As it is likely that heteromeric channels are formed with
native
WTCx43 in the transiently transfected WT fibroblasts,
the proline substitution of the 
S364PCx43 might also interfere
with the function or phosphorylation of 
WTCx43 in hetero-
meric connexons through steric hindrance.
Importantly, GJ assembly between either the 
S364PCx43/
KO or the 
S364PCx43/WT fibroblast transfectants is not en-
hanced following the elevation of cAMP, strongly suggesting
that 
S364PCx43 acts as a dominant negative, with respect to
enhancement of GJ assembly. It could be that 
S364ACx43 did
not inhibit enhanced assembly when expressed in the WT fi-
broblast because its conformation is more similar to that of
WTCx43. Phosphorylation of only some connexon subunits
of 
WTCx43 may be sufficient for interactions that take place
during enhanced assembly. We can conclude from this work
that S364 is either a critical site or resides in an important
domain of the Cx43 CT.
Stimulation of GJ assembly by cAMP requires 
activation of PKA but not increased Cx43 synthesis
Cx43 synthesis is stimulated by extended exposure to
cAMP-elevating agents in certain cell systems, resulting in
elevated levels of communication (Mehta et al., 1992; Dar-
row et al., 1995). Such increased synthesis in the WT fibro-
blast may occur prior to an increase in trafficking (Hendrix
et al., 1995). Importantly, 8Br-cAMP treatment did not in-
crease the synthesis of 
WTCx43 or of mutant Cx43 in trans-
fected KO fibroblasts, showing that elevation of Cx43 syn-
thesis is not required for enhanced assembly. Interestingly,
treatment with cycloheximide for recovery and reaggrega-
tion blocked cAMP-enhanced assembly between 
WTCx43/
KO fibroblasts and between WT fibroblasts (e.g., at 7-, 15-,
and 60-min reaggregation times). This was in spite of signif-
icant levels of dye coupling and Cx43 detected by Western
and immunoblotting after a 1-h assembly (Fig. 2). In sum,
these results suggest that another, short-lived protein partici-
pates in the assembly process.
Because inhibition of PKA by H89 blocks 8Br-cAMP–
stimulated GJ assembly when added immediately prior to
cell reaggregation, the enhancement of GJ assembly is prob-
ably not mediated by an increase in Cx43 synthesis (8Br-
cAMP is added at the beginning of recovery, so stimulation
of Cx43 synthesis would have already occurred). Blockage of
PKA with H89 inhibited both enhanced and control levels
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even basal levels of GJ formation. However, the Cx43 CT
was not a substrate for PKA, and the Cx43 phosphorylation
molar ratio was not increased during enhanced assembly.
Therefore, it is unlikely that phosphorylation of Cx43 by
PKA mediates enhanced assembly. In spite of this, either a
negative charge at 364 (e.g., glutamic acid) or a serine
(which was found to be phosphorylated in untreated cells)
allowed for elevation of GJ assembly by 8Br-cAMP. Muta-
tion of S364 did not obviously affect control levels of GJ
communication, whereas treatment with the PKA inhibitor
did. Therefore, it appears that phosphorylation at S364 by
an unknown kinase is necessary but not sufficient for en-
hanced assembly to occur, and that PKA activation is suffi-
cient for enhanced assembly given phosphorylation at S364.
An increase in the size and number of GJ punctae at inter-
faces between 
WTCx43-expressing WT fibroblasts was seen
with 8Br-cAMP treatment (Fig. 2 B), suggesting that con-
nexon trafficking or GJ assembly is enhanced. However, we
cannot exclude the possibility that 8Br-cAMP works in part
by indirect effects on Cx43 channel gating (e.g., open prob-
ability) in this system. Further analysis will be required
to determine whether PKA impacts enhanced assembly
through phosphorylation of a separate protein(s) that inter-
acts with Cx43. Such a phosphoprotein could be required
for the trafficking of Cx43 or recruitment of hemichannels
into GJs at the cell surface. Regulation of trafficking by PKA
is observed with several other proteins (Brignoni et al., 1995;
Howard et al., 2000; Zhou et al., 2000), indicating a general
control mechanism. For example, the transport of vesicular
stomatitis virus G glycoprotein to the cell surface is acceler-
ated by the activation of PKA and inhibited by H89 (Muniz
et al., 1996).
In summary, upregulation of GJ assembly by cAMP is
mediated by a PKA-dependent stimulation of connexon
trafficking that also requires microtubules (Paulson et al.,
2000). Importantly, the CT of Cx43 is instrumental for the
effects of cAMP, possibly by mediating an interaction with
intracellular trafficking proteins. The site of such an interac-
tion may lie in the region of the CT surrounding S364, the
phosphorylation of which appears to be necessary for cAMP-
enhanced GJ assembly.
Materials and methods
Cx43 antibodies
Cx43 polyclonal antibodies directed against residues 368–382 of human
and rat Cx43 were provided by Dr. Alan Lau (University of Hawaii, Hono-
lulu, Hawaii) and Sigma-Aldrich (#C6219). Antibody to the cytoplasmic
loop of Cx43 was provided by Dr. Nalin Kumar (Scripps Institute, La Jolla,
CA), and antibody specific for the NH2 terminus of Cx43 was provided by
Dr. Dale Laird (University of Western Ontario, London, Ontario, Canada).
Cx43IF1 and Cx43CT2 mouse monoclonal antibodies were generated
against the last 23 amino acids of rat Cx43.
Cells
Several immortalized fibroblast cell lines were generously provided by Dr.
Lau. Cells were cloned from the cardiac tissue of Cx43 KO fetal mice (KO
fibroblasts) and normal fetal mice (WT fibroblasts) (Martyn et al., 1997).
The KO fibroblasts and transfectants were propagated in low-glucose DME
with Hepes (LG DMEM; Life Technologies) containing 10% fetal calf se-
rum (Hyclone), 100 U/ml penicillin/streptomycin (Life Technologies), and
selective antibiotics where indicated. WT fibroblasts were propagated in
LG DMEM containing 10% fetal calf serum and penicillin/streptomycin.
WTCx43- and 
M257Cx43-transfected N2A cells, provided by Dr. Steve Taffet
(State University of NY, Syracuse, NY), were maintained in high-glucose
DMEM containing 10% fetal calf serum and penicillin/streptomycin with
800  g/ml geneticin (G418; Life Technologies). T51B rat epithelial cells
were donated by Dr. A. Boynton (Northwest Hospital, Seattle, WA) and
were propagated in LG DMEM with 5% FBS and penicillin/streptomycin.
All cells were kept in a humidified 5% CO2 incubator at 37 C.
Transfectants
Stably transfected 
WTCx43/KO fibroblasts were generated using rat 
WTCx43
cDNA (Beyer et al., 1987) in pZeoSV (Invitrogen) and lipofectamine (Life
Technologies), or Geneporter I (GTS) transfection protocols. 
WTCx43 fibro-
blast clones 22C-3 and 25C-2 were isolated by repeated dilution subclon-
ing in the selective antibiotic zeocin (350  g/ml). KO fibroblasts were sim-
ilarly transfected with rat 
WTCx43 cDNA truncated at amino acid 257
(
M257Cx43) subcloned into pZeoSV (
M257Cx43/KO fibroblasts), or serine to
glutamic acid, serine to alanine, and serine to proline 364 mutant rat Cx43
cDNAs (
S364ECx43, 
S364ACx43 and 
S364PCx43, respectively) subcloned into
pIRES1hyg (CLONTECH laboratories, Inc.). All mutant Cx43 cDNAs were
provided by Dr. Taffet and were sequenced to confirm the introduced mu-
tations and lack of extraneous mutations prior to transfection. Stably trans-
fected clones were isolated by repeated dilution subcloning using pro-
gressively higher concentrations of the selective antibiotic hygromycin
(150–500  g/ml). Clones were established and maintained in 100  g/ml
endothelial cell growth supplement (ECGS; Becton Dickinson). ECGS was
not included in the medium during experiments. At least three, usually
more, different clones of WT and mutant transfectants were tested in as-
sembly assays.
For transient transfections, rat 
M257Cx43, 
S364ECx43, 
S364ACx43, and
S364PCx43 cDNAs in pIRES1hyg or, for confirmatory experiments, in
pCDNA3.1, were transfected into 40–60% confluent WT fibroblasts using
Fugene 6 reagent (Roche). Cells were utilized 48 h after transfection. All
transfection efficiencies (ranging from 70–90%) were monitored using the
Green Lantern plasmid (Life Technologies).
Assembly assays
Cells were passaged two days before and fed 24 h before an experiment.
For GJ assembly assays, 70–80% confluent cells were dislodged from 100-
mm tissue culture dishes with 0.05% trypsin and 0.53 mM EDTA, and the
neutralized cell suspension centrifuged at 800 g for 5 min. Cells were re-
suspended to 4–5   10
5 cells/ml with or without test reagents and filtered
through a 35- M pore filter to remove cell clumps. Where indicated, cy-
cloheximide was added at a concentration in excess of that necessary to
inhibit protein synthesis by at least 96% after 10 min (Musil et al., 2000).
When possible, samples were coded for blind analysis. The single cell sus-
pension was allowed to recover for at least 1.5 h in 60-mm dishes coated
with nonadhesive poly(2-hydroxyethyl methacrylate) (1.5 mg/ml, POLY-
HEMA; Sigma-Aldrich) on a platform shaker at 37 C, 5% CO2 to insure
that GJ remnants were internalized (Preus et al., 1981). Cells were then re-
aggregated to confluency by centrifugation at 500 g for 5 min. Samples
were staggered to ensure that treatment times were as reported, and GJ
permeability was evaluated by iontophoretic microinjection of 4.0% Luci-
fer yellow CH (Mr   457) (Sigma-Aldrich) at the end of the assembly pe-
riod. A 5-s pulse of 1.1 nA was used to inject dye, and the number of cells
receiving dye was assessed 3 min later using a Zeiss IM35 fluorescence
microscope with a mercury lamp. Images were captured using a DVC-
1300 digital camera (DVC Company) and Image Pro 4.1 capture software
(Media Cybernetics).
SDS-PAGE and Western immunoblotting
Cell homogenates were analyzed by SDS-PAGE and Western immunoblot-
ting (TenBroek et al., 1994). Immunolabel was detected using enhanced
chemiluminescence. Results were recorded on Kodak X-OMAT AR film
during the first min of the reaction. Images for densitometry were collected
and analyzed using a Quant Mac densitometer and Image Quant software.
Variations in sample loading were corrected by calculating the ratio of the
band intensities of the autoradiographs over intensities of the correspond-
ing stained gel or by using a SDS and thiol reagent-compatible protein as-
say (Bio-Rad Laboratories).
In vitro phosphorylation
GST fusion proteins GST–Cx43CT (residues 236–382) and GST–Cx56CT
(residues 255–510), a gift from Dr. Viviana Berthoud (University of Chicago,
Chicago, IL) were prepared as previously described (Berthoud et al., 1997;
Lampe et al., 2000). GST–Cx43CT was phosphorylated by PKC, provided
by Dr. Mohammad Bazzi (University of Minnesota, St. Paul, MN). For phos-
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concentrations were 0.25  g/ml fusion protein, 5  g/ml PKA (Sigma P5511;
Sigma-Aldrich), 5  M cAMP, 10 mM MgCl2, 100  M ATP ([
32P]-ATP - Am-
ersham PB170, diluted with cold ATP to 0.3 Ci/mmol; Amersham Pharma-
cia Biotech), and 40 mM Tris-HCl (pH 8.0). The phosphorylation reactions
were initiated by the simultaneous addition of the ATP and MgCl2. After 30–
60 min the reactions were terminated by the addition of Laemmli sample
buffer, and fusion protein was analyzed using SDS-PAGE (10.0%).
Determination of the phosphorylation status of S364
For nonradioactive determination of phosphopeptides in the P2 isoform,
Cx43 was immunoprecipitated from eight 150-mm dishes of T51B cells
(Lampe et al., 2000). Briefly, the cells were rinsed in PBS, lysed in RIPA
buffer (100 mM NaCl, 50 mM NaF, 500  M Na3VO4, 2 mM PMSF, 0.5%
Triton X-100, 0.4% SDS, 25 mM Tris-HCl, pH 7.2), clarified, and immuno-
precipitated with a mixture of polyclonal and monoclonal antibody to
Cx43 (Sigma #C6219 and Cx43CT2, respectively; Sigma-Aldrich) that had
been crosslinked to protein A Sepharose. After SDS-PAGE and Coomassie
blue staining of the gel, the P2 mobility form of Cx43 was excised, diced,
washed in 25 mM ammonium bicarbonate, and digested overnight with
sequencing grade trypsin at 37 C (Promega) as previously described
(Shevchenko et al., 1996). After elution, the phosphorylated Cx43 peptides
were separated from nonphosphorylated by immobilized metal affinity
chromatography (Neville et al., 1997). The mixture of phosphopeptides
was examined by MALDI-TOF MS at the Fred Hutchinson Cancer Re-
search Center’s MS facility (Seattle, WA). To confirm the identity of the
mass species, the tryptic fragments (both phosphorylated and nonphos-
phorylated) were also analyzed via liquid chromatography/electrospray–
tandem mass spectrometry (Cooper et al., 2000).
Comparison of the phosphorylation status of 
WTCx43- and 
S364PCx43-expressing cells
KO fibroblasts expressing 
WTCx43 or 
S364PCx43 were metabolically labeled
with [
32P]i (NEN, NEX-053) at 1.0 mCi/ml for 3 h in phosphate-deficient
medium (GIBCO BRL). Cx43 was then immunoprecipitated and analyzed
by SDS-PAGE as described above. After excision of only the phosphory-
lated species, the gel was diced, washed, and dehydrated (Shevchenko et
al., 1996). The gel was then rehydrated in a solution containing 200 ng
modified trypsin (Promega) and 2  g of nonphosphorylated recombinant
fusion protein, GST–Cx43CT (carrier peptide), in 50 mM ammonium bicar-
bonate, pH 8.0, and incubated overnight at 37 C. Tryptic fragments were
then separated by reverse-phase HPLC on a Hewlett Packard 1050 LC us-
ing a Vydac C18 reverse phase column as previously described (Lampe et
al., 2000). 1-min fractions were counted without fluor in a Wallac scintil-
lation counter and MALDI-TOF MS was performed. Because equivalent
tryptic fragments of Cx43 from the Cx43CT, 
WTCx43, or 
S364PCx43 were ex-
pected to elute in essentially the same fractions, nonphosphorylated carrier
peptide GST–Cx43CT was included in the samples. The excess unlabeled
GST–Cx43CT fragments facilitated the mass identification of the co-eluting
WTCx43 or 
S364PCx43 phosphofragments. Although phosphorylation of a
peptide can reduce the elution time of short peptides by affecting the ab-
sorption of the hydrophobic “foot” region of a peptide, V347-R366 and
A371-I382 were of sufficient length that phosphorylation would not be ex-
pected to shift elution by more than a few seconds.
Statistics
Data are expressed as a sample mean   SEM. Number of injections (n) are
noted in the figures. Comparisons of sample means were made using the
Student’s t test and two-tailed probability (P). Each experiment contained
control samples. Vector alone controls were included in transient transfec-
tions whenever possible. Although Figs. 5 C and 6 C represent a compilation
of several experiments, individual experiments were analyzed separately.
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